Turning a health app into an actual medical device isn’t just about coding up a few screens and calling it a day. It’s a slog, and often a source of unpleasant surprises for startups who think the journey is as simple as launching another app on the store.
The first thing you need to grasp is the mountain of proof required before your digital health product can be trusted, regulated, and ultimately put in a patient’s hands. It’s not just about showing the app sort of works; it’s about indisputable evidence that it’s safe, reliable, and actually benefits the exact patient group it claims to help.
So what’s this evidence generation business anyway? Before anything goes live, you’re expected to dive deep into the scientific literature to check if others have already done related work. This typically means a systematic literature review, which is much less “skim through a handful of papers” and more “read through hundreds of studies to find relevant, sound scientific support.” This can eat up months easily, and that’s before you touch any code or design mockups.
Once you’ve convinced yourself, hypothetically, that your device idea has a shot at working, the real fun starts. You have to design clinical trials. Yes, actual, carefully controlled studies with real people. And no, you can’t just wing it or make last-minute changes as you go. If you want your work to be accepted by regulators, every tiny detail must be written down in a clinical protocol and approved by an ethics committee. This document covers who you’ll recruit, how many patients you’ll include, what tests or measures you’ll perform, and how you plan to analyze the data.
And yes, getting ethical approval is often a game of sending the protocol to multiple committees, each with their own quirks and demands, especially if your study covers different regions.
Then there’s the recruitment headache. Getting patients involved is by no means straightforward. It’s not just about putting an ad out there. Physicians or healthcare providers, who are already juggling a million other things, often need to be the ones to inform patients about the study. They need to explain what’s involved and get the patients’ informed consent, which is a process requiring time, paperwork, and patient reflection. Patients need time to think about it, often 24 hours or more, and then come back to confirm participation. All these back-and-forths slow things down.
Meanwhile, your clinical team needs to manage a complicated dance of randomization, allocating patients to control or intervention groups, making sure the data is collected, documented, and kept clean. Documenting everything isn’t just a suggestion, it’s a legal requirement, and while you could try Excel to keep track, that’s flirting with disaster when dealing with hundreds of participants.
By the way, this whole setup phase just before any actual testing begins can realistically take a year or even more, and that’s if you’re lucky, experienced, and have a network of helpers lined up.
And here’s a fun fact for your nightmares: clinical trials aren’t cheap. A decent randomized controlled trial (RCT), which is the gold standard, will easily run you around 200,000 euros just for conducting the study. That figure excludes the company’s internal personnel and infrastructure costs. So there is one shot, no safety nets if you mess it up. Pick the wrong outcome measure, mess up the protocol, or recruit the wrong patient types and you might have to kiss that money goodbye without any usable results.
The stakes aren’t just financial, they’re existential. If your study doesn’t prove your app reduces, say, back pain by your preset criteria, even if it’s off by a fraction of a percent, you have to reject your hypothesis. That could mean your app doesn’t get certified, won’t qualify for reimbursement, and essentially gets banned from entering the healthcare system.
Sure, real-world data from people actually using the app at home is gaining attention, but regulators, at least in parts of Europe, still hold their nose and prefer RCTs. That’s the pharmaceutical industry’s imprint showing through, where rigorous, controlled testing is non-negotiable.
Beyond the clinical data, there’s a jungle of regulations nobody warned you about. Every medical device, whether it’s a screw for surgery or a health app, must comply with strict standards for safety and performance. If you’re a Class 1 medical device, for example, a digital physiotherapy app, you face less scrutiny than higher risk classes but you’re still burnt by the same rulebook. This includes setting up a robust quality management system and an information security system to protect patient data, which again costs money and resources.
On the topic of safety, don’t be fooled by the fact your app is “just software.” Incorrect data or glitchy advice can lead to dangerous decisions, like mistiming insulin doses or unsafe exercises, with very real consequences. Regulatory bodies take this seriously, and so should you.
Then there’s the unenviable task of convincing healthcare professionals and insurers to actually back you. You can have the best app and clinical data, but if doctors don’t prescribe it or insurers won’t reimburse, you’re shaping sandcastles at low tide. Early conversations with payers and providers are crucial, but even then, the business of digital health is a cold, tough market. Some early “success” stories have ended in bankruptcy despite ticked regulatory boxes.
You might wonder about going direct to consumer to bypass this convoluted system. Fair question. Selling to patients directly without being tangled in insurance gymnastics sounds like a lifesaver. But here’s the catch: your price has to be rock-bottom because individual users aren’t exactly lining up to spend hundreds on an app, especially if they think their health insurance should cover it. And to build, maintain, support, and monitor a medical device-compliant app, those costs add up fast. The reality is, charging 50 euros is probably not going to cut it if you want to stay sustainable and compliant.
What struck me most is how we seem to have inverted priorities when it comes to healthcare affordability. I recently paid a modest 35 euros co-pay for several physical therapy sessions, which felt like a steal given the quality and personal attention I received. Meanwhile, apps designed to ease the burden on healthcare systems cost hundreds, and people balk at the expense for software. This mismatch highlights a deeper problem: regulatory and business frameworks that make medical-grade digital health products expensive, complicated to use, and hard to access for the very patients they aim to help.
To top it all off, usability often takes a backseat to red tape, with multi-factor authentication, frequent password changes, and data security protocols turning potential users off before they even begin. If a patient struggles to log in repeatedly or gets frustrated with complex procedures, they drop out, and the health benefits evaporate.
Balancing data security with accessibility is a tightrope act. People aren’t software engineers, yet they’re expected to handle complex security measures that can be downright user-hostile. Somewhere along the line, we forgot that technology is for people, not regulations for regulations’ sake.
Ultimately, the message is clear: effective digital health apps require not just brilliant science and rigorous trials, but also a pragmatic approach to regulation, fair pricing, and genuine usability. If these pieces don’t fit together, innovation risks becoming a white elephant.
And for those considering jumping into this madness, get ready. It’s a marathon nobody warned you about. But if you do it right, the payoff isn’t just profit, it’s making a real difference where it counts, improving patient care in a system that desperately needs it.
Commenting Rules: Being critical is fine, if you are being rude, we’ll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for your input.
Join a growing community. Every Friday I share the most recent insights from what I have been up to, directly to your inbox.
